Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2 - Wikidata - awgldk - TriplyDB

Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2

Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2

http://www.wikidata.org/entity/Q37409373

about

Beyond D-luciferin: expanding the scope of bioluminescence imaging in vivo Bioluminescence imaging in live cells and animals.A review of novel optical imaging strategies of the stroke pathology and stem cell therapy in stroke MBL-II-141, a chromone derivative, enhances irinotecan (CPT-11) anticancer efficiency in ABCG2-positive xenografts Altered glycaemia differentially modulates efflux transporter expression and activity in hCMEC/D3 cell line.Molecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes.The Inhibitor Ko143 Is Not Specific for ABCG2 The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicity In Vivo Imaging of Human MDR1 Transcription in the Brain and Spine of MDR1-Luciferase Reporter Mice.Bioluminescent imaging of ABCG2 efflux activity at the blood-placenta barrier The Drug Excipient Cyclodextrin Interacts With d-Luciferin and Interferes With Bioluminescence Imaging Nilotinib Effects in Parkinson's disease and Dementia with Lewy bodies.Imaging transporters: Transforming diagnostic and therapeutic development.In vivo bioluminescence imaging of neurogenesis - the role of the blood brain barrier in an experimental model of Parkinson's disease.Efflux proteins at the blood-brain barrier: review and bioinformatics analysis.Influence of breast cancer resistance protein and P-glycoprotein on tissue distribution and excretion of Ko143 assessed with PET imaging in mice.In Vivo Bioluminescent Imaging of ATP-Binding Cassette Transporter-Mediated Efflux at the Blood-Brain Barrier.

P2860

Q27026277-F600A3F7-346B-4355-8113-58B62246106B Q30759788-D8616A38-5764-4B6D-86DA-F36146F3148A Q30846905-5B869B6C-64FC-4203-82C7-465F8B2BCD82 Q35068041-B74142EF-2AFE-4295-9138-A504FC4315E8 Q35685226-6BF0AAFB-052D-4BE0-9B20-8CCBDE844B61 Q35768413-3D2FD521-8580-4C9A-B6D1-1BA12EC0B17D Q35962045-C3118C72-1A84-4D13-88FD-8FD35654E4D4 Q36019903-4D0BEF50-8F9A-41EE-8E5D-2B8810C048D8 Q36186153-C58F5320-F12D-420D-99B6-6640FDD1420B Q36555565-AE019B55-F58E-4997-8B57-E7390D3143EC Q37170669-415BABE4-F495-46F1-9DE9-46A44BBE49DB Q37225128-58B1A184-869A-4195-A7EA-73D3789FE89D Q38871905-54F803FC-05DA-46F7-9DE6-313FDD068635 Q38962780-A19BD531-2231-4482-B186-802FCDE53D0E Q39290800-C164D2AE-79C6-4C8C-B9C1-A78E1D7500A8 Q47845084-EB0DCD84-605E-4938-8EE7-EF1E769D117C Q48619564-B3D8B784-AA00-40A5-852B-B1FEB08D2F0B

P2860

Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2

http://www.wikidata.org/entity/Q37409373

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Bioluminescent imaging of drug ...... iated by the transporter ABCG2

@en

Bioluminescent imaging of drug ...... ated by the transporter ABCG2.

@nl

type

label

Bioluminescent imaging of drug ...... iated by the transporter ABCG2

@en

Bioluminescent imaging of drug ...... ated by the transporter ABCG2.

@nl

prefLabel

Bioluminescent imaging of drug ...... iated by the transporter ABCG2

@en

Bioluminescent imaging of drug ...... ated by the transporter ABCG2.

@nl

P1433

Q37409373-387D1F0E-6F7D-40EE-97CD-87190CC774A3

P1476

Q37409373-7AD7E447-527F-492E-A51A-8A397274D95D

P2093

Q37409373-1FFA956E-278D-4EF4-A084-5D58CADC914D

Q37409373-4E0EB250-DEA8-4EC6-A374-D0B94ACD22AB

Q37409373-558D4D0E-323B-4512-9453-E23EE2F2A218

Q37409373-8D9DBDC0-4986-451F-8A61-11AC2E1D076B

Q37409373-DFE80595-8AF6-4ABC-9A22-34F80AA467CF

Q37409373-F9F2B977-519F-4C13-B039-E5F9E6C24ECF

Q37409373-FFC9CD50-2909-46D7-BA44-22F2DD0D6BE5

P2860

Q37409373-1049C074-CBC8-4CDA-AC98-38E96F9D52C8

Q37409373-12ADB860-CC16-41A3-AAE5-AC4F904B5A57

Q37409373-141C09A8-AEF2-4739-994F-88458E9BD294

Q37409373-160B88D4-735A-4BD2-A2FF-0C4D84271145

Q37409373-1E4CF1CF-8603-4EDC-B36F-3CCA88F49D97

Q37409373-20B6C146-E68A-44D7-9E92-F5D4379482E9

Q37409373-2408734A-0BD4-4A78-94EC-447D27A37621

Q37409373-2442E51A-786C-4F8D-A9AB-3FC3F3FC3159

Q37409373-2B49C68E-FB60-4BC6-8207-B2865A7B6B3A

Q37409373-2E5BD26A-17A4-43A7-BFCD-C540E884A4D2

P304

Q37409373-85C4D582-1D06-437B-8428-DA4D347D98DA

P31

Q37409373-71E5F0BB-53E7-4AE1-A08B-2C7B3E2F8148

P356

Q37409373-8AD72F5A-971C-4FA5-A07E-7BCBD4E8F520

P407

Q37409373-3B0599C9-67CB-4BCF-AC19-FA1E28576155

P433

Q37409373-E4967A9E-70E5-484D-B42E-866EC35C3B60

P478

Q37409373-BFD2966B-D21E-473C-9E5A-DFF9D8257583

P50

Q37409373-8017E42F-0AAA-4400-896F-7317D1577845

P577

Q37409373-647113EA-3001-4048-8A22-BC54CAA03BFF

P5875

Q37409373-48432E97-8CB9-41B5-824D-0C18CEA32444

P698

Q37409373-36FC3BD9-B13C-4183-9FD2-992CDBD30593

P921

Q37409373-240084E0-F62C-4D11-AFB4-9D1DDF6417F6

Q37409373-7356DF51-D8F4-468C-AEA4-E31D6B37638F

P932

Q37409373-25D3B7F5-B38F-41CB-8E3D-B80B30CCA4A4

P356

PNAS.1312159110

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Bioluminescent imaging of drug ...... iated by the transporter ABCG2

@en

P2093

Bih-Rong Wei

http://www.w3.org/2001/XMLSchema#string

Ki-Eun Chang

http://www.w3.org/2001/XMLSchema#string

Matthew D Hall

http://www.w3.org/2001/XMLSchema#string

Michael M Gottesman

http://www.w3.org/2001/XMLSchema#string

R Mark Simpson

http://www.w3.org/2001/XMLSchema#string

Suneet Shukla

http://www.w3.org/2001/XMLSchema#string

Suresh V Ambudkar

http://www.w3.org/2001/XMLSchema#string

P2860

The blood-brain barrier: bottleneck in brain drug development

Boosting bioluminescence neuroimaging: an optimized protocol for brain studies

Novel in vivo imaging analysis of an inner ear drug delivery system in mice: comparison of inner ear drug concentrations over time after transtympanic and systemic injections

Non-invasive quantification of brain tumor-induced astrogliosis.

Treatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunities

Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity.

Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay.

N-desmethyl-loperamide is selective for P-glycoprotein among three ATP-binding cassette transporters at the blood-brain barrier

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux

P304

20801-20806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1312159110

http://www.w3.org/2001/XMLSchema#string

P407

P433

51

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

Joshua Bakhsheshian

P577

2013-12-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259115163

http://www.w3.org/2001/XMLSchema#string

P698

24297888

http://www.w3.org/2001/XMLSchema#string

P921

bioluminescence

blood–brain barrier

P932

3870704

http://www.w3.org/2001/XMLSchema#string